Semaglutide and Domperidone Drug Interaction
No specific direct drug–drug interaction between semaglutide and domperidone has been documented in the available prescribing information and pharmacokinetic interaction studies reviewed. [1]
Mechanistic Interaction: Gastric Emptying and Oral Drug Absorption
Semaglutide delays gastric emptying, which can affect the absorption of concomitantly administered oral medications taken with oral semaglutide (Rybelsus). [1] Domperidone is used as a prokinetic agent and may be administered to treat nausea and dyspepsia related to delayed gastric emptying, but this does not constitute a known pharmacokinetic interaction with semaglutide. [2]
Pharmacokinetic Interaction: Clinical Trial Data
A pharmacokinetic study of oral semaglutide showed that delayed gastric emptying can slightly alter early absorption characteristics of some orally administered drugs, such as by a modest delay and Cmax changes, without indicating a specific interaction pattern for domperidone. [3]
Cardiac Electrophysiology Considerations
Semaglutide has not shown clinically relevant QTc prolongation in thorough QT testing in healthy subjects. [4] Domperidone has known potential for QT interval effects and is evaluated for QT risk in thorough QT research, with QT findings depending on dose and patient factors. [2]
Practical Clinical Considerations
If oral semaglutide (Rybelsus) is used, separation from other oral medications may be relevant in practice due to semaglutide-related delayed gastric emptying effects on oral drug absorption. [1] If domperidone is used, reassessment for QT-risk factors is appropriate, given domperidone’s QT-related safety considerations. [2]
Safety Monitoring
Monitoring for additive gastrointestinal adverse effects is appropriate because both agents can be associated with nausea and GI symptoms depending on dosing and indication. [1] Monitoring for cardiac symptoms consistent with arrhythmia risk (for example, syncope or palpitations) is appropriate when domperidone is prescribed in patients with QT-risk factors. [2]